Macro Helix LLC

What Macro Helix LLC does

Macro Helix LLC is a Dallas-Fort Worth-based healthcare technology company and wholly-owned subsidiary of McKesson Corporation that provides software and services for administering the federal 340B Drug Pricing Program. Its platform is built around 340B Architect, a split-billing and contract-pharmacy administration system used by approximately 1,000 covered entities — hospitals, health systems, specialized clinics, and federal grantees — across 48 U.S. states, representing roughly 40% of 340B-eligible hospitals in the country. The product portfolio extends the core Architect platform with intelligent modules including 340B RxCorrelate (referral capture), 340B Central Split and 340B Order Optimizer (central order fulfillment and split-order optimization), 340B Impact (business-intelligence analytics available to joint Macro Helix/McKesson customers), 340B Validate (manufacturer-side duplicate-discount validation), 340B Gateway (retail-chain 340B consolidation), and 340B Written Location and 340B Monitor (eligibility testing and compliance alerts). A separate Patient Assistance Program offering, anchored by the PAP Recovery Navigator software, supports manufacturer-sponsored free drug, copay assistance, and 501c3 program identification and workflow automation.

Macro Helix monetizes primarily through enterprise subscription and licensing fees for 340B Architect and its modules, augmented by paid HRSA audit-support professional services and patient-assistance-program recovery engagements. The company sells through a high-touch enterprise field-sales motion with dedicated account representatives, no implementation fees, and ongoing education and consultation. Distribution is anchored by McKesson's pharmaceutical wholesale network while remaining distributor-agnostic — Macro Helix explicitly supports integrations with Cardinal Health and AmerisourceBergen — and contract-pharmacy-side access is tied to McKesson pharmacy management systems.

The company operates as a private LLC (Delaware-incorporated, Texas-headquartered) with 101–250 employees and a leadership team including a VP/GM, VPs of IT/R&D, Product Strategy/Business Development, and Customer Service/Account Management, plus a regulatory advisor. Its competitive positioning rests on McKesson-backed distribution, a broad multi-module architecture, and specialized regulatory expertise in HRSA compliance and manufacturer-restriction management, with no public revenue disclosure available.

Name

Macro Helix LLC

Legal name

Macro Helix LLC

Website

https://macrohelix.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

Macro Helix LLC, a wholly-owned McKesson subsidiary, provides 340B Drug Pricing Program management software to approximately 1,000 U.S. hospitals, health systems, and contract pharmacies, covering ~40% of 340B-eligible hospitals through its 340B Architect platform and adjacent modules.

Ownership category

akta.pro rank

Product category

340B Drug Pricing Program Management Software

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

akta.pro primary industry

340B Program Administration & Contract Pharmacy Services (HLAFALAL)

akta.pro secondary industries

340B Program Administration & Support (HLAEAKAJ), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price) (HLAIAKAE)

Keywords

• 340B program management
• Pharmacy compliance software
• Healthcare IT solutions
• Drug pricing software
• Covered entity software

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. 340B Administration Software: Software subscription and licensing fees for 340B Architect platform and associated modules including split billing, contract pharmacy administration, analytics, and compliance tools.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Macro Helix LLC provides software and services that help hospitals, health systems, federally qualified health centers (FQHCs), and other safety-net covered entities operate, audit, and optimize their participation in the federal 340B Drug Pricing Program. Its flagship 340B Architect platform and adjacent modules support split-billing, contract pharmacy oversight, patient assistance program recovery, and audit readiness.

Product overview

Macro Helix LLC offers a platform-plus-modules architecture centered on 340B Architect, its flagship administration software. The portfolio includes intelligent modules for split billing (340B Central Split, 340B Order Optimizer), business intelligence analytics (340B Impact), referral capture (340B RxCorrelate, 340B Written Location, 340B Monitor), manufacturer compliance (340B Validate), patient savings (Community Prescription Assistance, Patient Assistance Program with PAP Recovery Navigator), audit support services, and retail chain management (340B Gateway). These solutions work together to help covered entities and contract pharmacies manage their 340B programs, with features including automated NDC/CDM verification, perpetual inventory replenishment, standard and user-defined reporting, and HRSA compliance support.

Differentiator

Problem solved

Functional benefit

Brands

• 340B Architect: Flaghip 340B administration software solution for covered entities featuring split billing and contract pharmacy administration, referral capture through 340B RxCorrelate, and HRSA compliance and audit services.
• 340B Gateway
• 340B Central Split
• 340B Impact
• 340B RxCorrelate
• 340B Validate
• Community Prescription Assistance
• Patient Assistance Program (PAP)
• PAP Recovery Navigator

Products and services

• 340B Architect
• 340B Impact
• 340B Validate
• 340B RxCorrelate
• 340B Central Split
• 340B Gateway
• Audit Support
• Patient Assistance Program (PAP) Recovery Navigator
• Community Prescription Assistance

Quantifiable outcome

• Health systems saved 2x more in recovery through McKesson's PAP offering than with competitors' programs.
• +3 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature10 records

Partnerships

One partnership is on record.

• McKesson CorporationcoreOthersMacro Helix is a wholly-owned subsidiary of McKesson Corporation. This ownership provides Macro Helix with nearly 200 years of healthcare leadership and perspective, extensive resources, stability in the turbulent 340B industry, and access to additional solutions across McKesson's lines of business. McKesson's data security measures overlay Macro Helix's system for enhanced cybersecurity. The relationship enables joint customer solutions like 340B Impact analytics for shared customers.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• SunRx: 340B program administration vendor offering split-billing software and contract pharmacy services to covered entities, comparable in product scope and target customer to Macro Helix.
• CaptureRx: 340B administration and contract pharmacy platform serving covered entities and safety-net hospitals. Directly competes with Macro Helix in split-billing and HRSA compliance workflows.
• Sentry Data Systems: Direct competitor offering 340B split-billing, contract pharmacy administration, and program compliance software to hospitals and health systems — directly comparable product set to Macro Helix's 340B Architect.
• RxStrategies: Specialized 340B program management company providing split billing, contract pharmacy, and consulting services to hospitals and health systems — overlapping customer base and product offering with Macro Helix.
• Wellpartner: Contract pharmacy and 340B program administrator serving covered entities and retail pharmacy partners, directly comparable to Macro Helix's contract pharmacy administration modules.

Broad incumbents

• Cencora (formerly AmerisourceBergen): Major pharmaceutical distributor offering distribution services and 340B program support to covered entities; competes with McKesson-integrated solutions and serves as a comparable broad incumbent in the 340B ecosystem.
• McKesson Corporation: Parent company and largest U.S. pharmaceutical wholesaler; provides adjacent 340B-related services and pharmaceutical distribution that Macro Helix integrates with, making it both an owner and a broader-market incumbent.
• Cardinal Health: Large pharmaceutical distributor offering 340B distribution and program services; competes broadly with the McKesson-Macro Helix partnership for covered entity pharmaceutical purchasing.

Others

• Surescripts: Pharmacy IT and health information network enabling ePrescribing and medication intelligence; adjacent ecosystem player whose infrastructure Macro Helix integrates with for 340B eligibility testing.

Emerging players

• Visante: Specialty pharmacy and 340B consulting/services firm working with health systems on program optimization and compliance — adjacent to Macro Helix with partial product overlap and complementary consulting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/macro-helix-inc.

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Macro Helix LLC